American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy

Davis, Brian J.; Horwitz, Eric M.; Lee, William R.; Crook, Juanita; Stock, Richard G.; Merrick, Gregory S.; Grimm, Peter; Stone, Nelson N.; Potters, Louis; Zietman, Anthony L.; Zeléfsky, Michael J.

doi:10.1016/j.brachy.2011.07.005

Cited by 403 publications

(299 citation statements)

References 153 publications

Supporting

Mentioning

294

Contrasting

Unclassified

Order By: Relevance

“…There are several other publications dealing with the performance, specifications, and quality control of low‐dose‐rate (LDR) permanent seed brachytherapy 4, 5, 6, 7, 8, 9, 10, 11. Most of these publications have extensive reference lists.…”

Section: System Descriptionmentioning

confidence: 99%

“…From the physicist's point of view, there is a convergence of many technologies into a single procedure. American Association of Physicists in Medicine (AAPM) Task Groups 43U1,7 64,6 137,10 138,11 186 30 as well as the American Brachytherapy Society 5, 31 and Groupe Européen de Curiethérapie (GEC) and the European Society for Radiotherapy and Oncology (GEC‐ESTRO) guidelines,8 are reference documents for these procedures. The three areas of importance for all implants are: imaging, dosimetry, and radiation protection.…”

Section: System Descriptionmentioning

confidence: 99%

See 1 more Smart Citation

COMP report: CPQR technical quality control guidelines for low‐dose‐rate permanent seed brachytherapy

Beaulieu¹,

Radford

Villarreal-Barajas

2018

J Applied Clin Med Phys

View full text Add to dashboard Cite

The Canadian Organization of Medical Physicists (COMP), in close partnership with the Canadian Partnership for Quality Radiotherapy (CPQR) has developed a series of Technical Quality Control (TQC) guidelines for radiation treatment equipment. These guidelines outline the performance objectives that equipment should meet in order to ensure an acceptable level of radiation treatment quality. The TQC guidelines have been rigorously reviewed and field tested in a variety of Canadian radiation treatment facilities. The development process enables rapid review and update to keep the guidelines current with changes in technology. This article contains detailed performance objectives and safety criteria for low‐dose‐rate (LDR) permanent seed brachytherapy.

show abstract

Section: System Descriptionmentioning

confidence: 99%

Section: System Descriptionmentioning

confidence: 99%

COMP report: CPQR technical quality control guidelines for low‐dose‐rate permanent seed brachytherapy

Beaulieu¹,

Radford

Villarreal-Barajas

2018

J Applied Clin Med Phys

View full text Add to dashboard Cite

show abstract

“…Permanent brachytherapy has been proven an effective approach for the tumors located in prostate [1]- [4], thoracic cavity [5]- [8], head and neck [9]- [11] etc. In the operation, radioactive seeds are directly implanted into target volume via template and puncture needles.…”

Section: Introductionmentioning

confidence: 99%

A Double Iteration Greedy Heuristic Approach for Permanent Brachytherapy Planning

Liang¹,

Zhou²,

Liang³

et al. 2015

IJAPM

View full text Add to dashboard Cite

This paper presents a double iteration greedy heuristic (DIGH) approach for permanent brachytherapy treatment planning. The DIGH approach adopts a greedy heuristic seed selection (GHSS) procedure to obtain a preliminary plan. In this process, the potential seeds are evaluated according to their ability to irradiate target volume while sparing organs-at-risk (OARs). Their impact on dosimetric homogeneity within target volume is also taken into account. The preliminary treatment plan generated by the GHSS procedure is further refined by the double iteration (DI) procedure. The DI procedure removes the needles containing only one seed (single seed) and implements the GHSS procedure again to obtain a temporary plan. The DI procedure terminates when the needle number of the temporary plan does not decrease. This process is guided by constantly removing the undesired part rather than imposing extra constrains. The efficiency and robustness of the DIGH approach is tested on three kinds of typical patient cases. For these cases, treatment plans are generated in less than 30s. The dosimetric distribution of these treatment plans achieves satisfactory dosimetric distribution. The numbers of used needles are kept within acceptable level. The experimental results demonstrate that the DIGH approach is fast, effective and robust. It has the potential to be used for intraoperative brachytherapy treatment planning in operation room.

show abstract

“…One month after receiving EBRT to 4,500 cGy, patients underwent a LDR brachytherapy boost according to American Brachytherapy Society consensus guidelines (9). Briefly, patients were placed under general anesthesia and 14-24 interstitial needles were advanced into the prostate.…”

Section: Ebrt and A Ldr Brachytherapy Boostmentioning

confidence: 99%

External beam radiation therapy and a low-dose-rate brachytherapy boost without or with androgen deprivation therapy for prostate cancer

et al. 2014

View full text Add to dashboard Cite

ARTICLE INFO ______________________________________________________________ ______________________Purpose: To assess outcomes with external beam radiation therapy (EBRT) and a low--dose-rate (LDR) brachytherapy boost without or with androgen deprivation therapy (ADT) for prostate cancer. Results: Median follow-up was 5.2 years (range, 1.1-12.8 years). There was no statistically-significant difference in biochemical disease-free survival (bDFS), distant metastasis-free survival (DMFS), or overall survival (OS) without or with ADT. Also, there was no statistically-significant difference in bDFS, DMFS, or OS with a palladium-103 vs. an iodine-125 LDR brachytherapy boost.Conclusions: There was no statistically-significant difference in outcomes with the addition of ADT, though the power of the current study was limited. The Radiation Therapy Oncology Group 0815 and 0924 phase III trials, which have accrual targets of more than 1,500 men, will help to clarify the role ADT in locally-advanced prostate cancer patients treated with EBRT and a brachytherapy boost. Palladium-103 and iodine-125 provide similar bDFS, DMFS, and OS.

show abstract

American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy

Cited by 403 publications

References 153 publications

COMP report: CPQR technical quality control guidelines for low‐dose‐rate permanent seed brachytherapy

COMP report: CPQR technical quality control guidelines for low‐dose‐rate permanent seed brachytherapy

A Double Iteration Greedy Heuristic Approach for Permanent Brachytherapy Planning

External beam radiation therapy and a low-dose-rate brachytherapy boost without or with androgen deprivation therapy for prostate cancer

Contact Info

Product

Resources

About